FDA Approved: COSELA — Original Application (G1 Therapeutics, Inc.)

View source ↗

Summary

The FDA approved COSELA (trilaciclib) from G1 Therapeutics in an original NDA to preserve bone marrow function during chemotherapy in adults with small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Cosela (trilaciclib)

Snippet

ORIG AP for COSELA (TRILACICLIB)